In diabetic neuropathy, HMGB1 increases NFκB activity (Alomar et al., 2021), while in diabetic retinopathy, HMGB1 has been shown to upregulate NFκB specifically by inhibiting the activity of IKB-α (Liang et al., 2020). Here, NFKBIA is linked to diabetic retinopathy.